Laura McLane

Overview

Laura McLane serves as head of McDermott’s Boston Litigation Practice Group and as co-chair of the Firm’s Healthcare Litigation Team. Laura represents national and international clients in healthcare, securities and other government enforcement matters, both civil and criminal.

A significant part of Laura’s practice is devoted to representing healthcare and other companies, as well as individuals, in government investigations and qui tam litigation based on the False Claims Act (FCA) and related statutes, including the Anti-Kickback Statute and the Stark Law. Laura represents clients in FCA cases pending in federal district courts throughout the country, as well as in federal courts of appeals and the United States Supreme Court. Laura has extensively litigated the myriad issues that typically arise during the course of most FCA cases. In addition, she routinely advises clients concerning all aspects of parallel civil and criminal investigations relating to Medicare and Medicaid billing and other government contracting issues, including negotiating with the government and managing clients’ responses to civil investigative demands and large-scale investigative subpoenas. Laura also conducts internal investigations for clients and works with them on a day-to-day basis to help enhance their internal FCA compliance mechanisms.

Laura represents individual and corporate clients in securities fraud investigations and civil enforcement actions brought by the US Securities and Exchange Commission (SEC), both at the trial and appellate levels. For example, she tried a multi-week case before the SEC’s Chief Administrative Law Judge (ALJ) and won, defeating the SEC’s Division of Enforcement in connection with a litany of securities fraud charges arising from the sub-prime mortgage crisis. When the Commission later reversed the ALJ’s decision, Laura appealed to the US Court of Appeals for the First Circuit, which vacated the Commission and exonerated her client. Laura has also achieved successful pre-litigation results for clients in SEC investigations, including convincing the SEC to decline to pursue charges as a result of the Wells process.

Laura also represents clients in complex business disputes and products liability actions, and she routinely defends other law firms in professional liability matters.

Finally, Laura has substantial pro bono experience at the federal level, representing clients from start to finish in connection with a variety of criminal charges.

Show Less

Results

Defends national and global healthcare providers spanning multiple provider types, including dentistry, dialysis, behavioral health, ambulance services and hospitals, in government investigations and related qui tam FCA litigation; also defends medical device and pharmaceutical manufacturers in government investigations and qui tam litigation
Successfully advocated on behalf of numerous clients in persuading prosecutors and enforcement agencies to decline to bring charges or intervene
Obtained writ of certiorari from the United States Supreme Court on behalf of a healthcare provider client in an FCA case, after which the Court unanimously reversed an adverse decision of the court of appeals

Recognitions

The Best Lawyers in America 2019 & 2020, Litigation – Health Care
Super Lawyers, Rising Star
The Legal 500 United States 2019

Credentials

Education
Boston University School of Law, JD, cum laude, 1999
Emory University, BA, 1996

Admissions
Massachusetts

Overview

Results

Recognitions

Credentials

Servizi e Settori:

Regional Markets: